QIAGEN
QIAGEN serves more than 500,000 customers around the globe, all seeking answers from the building blocks of life – DNA, RNA and proteins. They deliver sample-to-insight solutions for molecular testing of blood, tissue and other materials, propelling their customers from start to finish to unlock new insights.
Latest QIAGEN Content
eBook
Realize the Full Potential of Digital PCR
Uncover the rationale and methodology behind the integration of dPCR into workflows for optimized performance in cell and gene therapy, cancer research, gene expression analysis, microbial detection and more.
Product News
Evonetix Appoints Colin McCracken as Chief Executive Officer
EVONETIX LTD, the synthetic biology company bringing semiconductor technology to DNA synthesis, today announced the appointment of Colin McCracken as Chief Executive Officer with immediate effect.
Product News
QIAGEN Expands Syndromic Testing Portfolio
QIAGEN N.V. has announced the launch of QIAstat-Dx Rise – a high-capacity version of the QIAstat-Dx automated syndromic system – and enhancements to the menu of tests for the fully integrated one-step molecular testing solution that provides results in about one hour.
Product News
Element Biosciences Launches the AVITITM System To Democratize Access to Genomics
Element Biosciences Inc. has announced the commercial launch of the Element AVITI™ System, a benchtop sequencer offering an unrivaled combination of performance, cost and flexibility.
Advertisement
